AWARENESS ABOUT INTRATHECAL DRUG ADMINISTRATION AMONG DENTAL STUDENTS

Authors

  • Nithyanandham Masilamani Tutor, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai,India Author
  • Dhanraj Ganapathy Professor &Head of Department, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author

DOI:

https://doi.org/10.61841/b1jg0f33

Keywords:

Awareness, intrathecal, drug, dental students

Abstract

Intrathecal administration includes the immediate infusion of the medication in cerebrospinal fluid (CSF) internal to the intrathecal space of the spinal column. The intrathecal course permits direct medication delivery to the CSF by evading the blood-cerebrum hindrance. It permits conveyance of small medication dosages, and the event of adverse effects is decreased compared with systemic courses of medication administration. This survey was performed for assessing the awareness about intrathecal drug administration among dental students. A cross-sectional study was done with a self-administered questionnaire with 10 questions circulated among 100 dental students. The questionnaire assessed the awareness about intrathecal drug delivery in medical applications, their medicinal uses, drugs administered, mechanism of action, and side effects. The responses were recorded and analyzed. 17% of the respondents were aware of medical uses of intrathecal drug delivery; 13% were aware of the drugs used in intrathecal drug delivery . 10 % were aware of the mechanism of action of intrathecal drug delivery . 7% were aware of side effects of intrathecal drug delivery . The awareness about intrathecal drug administration among dental students is not adequate. Increased awareness programs and continuing dental education programs in intrathecal drug delivery should be initiated to improve the awareness levels. 

Downloads

Download data is not yet available.

References

1. Anderson, V. C., & Burchiel, K. J. (1999). A Prospective Study of Long-term Intrathecal Morphine in the

Management of Chronic Nonmalignant Pain. In Neurosurgery (Vol. 44, Issue 2, pp. 289–300).

https://doi.org/10.1097/00006123-199902000-00026

2. Bharathi, M., Professor, A., Department of Anaesthesiology, Siddhartha Medical College, Vijayawada,

India, A. P. 520008, Kiran, I., Professor, A., Department of Anaesthesiology, Siddhartha Medical College,

Vijayawada, & India, A. P. 520008. (2019). Single-Dose Intrathecal Fentanyl (25 Μgms) 2.5 Mg of 0.5%

Bupivacaine (Heavy) in the Second Stage of Labor to Control Labor Pain in Normal Labor. In Indian Journal of Anesthesia and Analgesia (Vol. 6, Issue 2, pp. 407–412).

https://doi.org/10.21088/ijaa.2349.8471.6219.6

3. Brescia, F. J. (1987). An overview of pain and symptom management in advanced cancer. In Journal of

Pain and Symptom Management (Vol. 2, Issue 2, pp. S7–S11). https://doi.org/10.1016/s0885-

3924(87)80034-9

4. Chatelut, E., Kim, T., & Kim, S. (1993). A slow-release methotrexate formulation for intrathecal

chemotherapy. In Cancer Chemotherapy and Pharmacology (Vol. 32, Issue 3, pp. 179–182).

https://doi.org/10.1007/bf00685832

5. Coffey, R. J., & Burchiel, K. (2002). Inflammatory Mass Lesions Associated with Intrathecal Drug

Infusion Catheters: Report and Observations on 41 Patients. In Neurosurgery (Vol. 50, Issue 1, pp. 78–87).

https://doi.org/10.1227/00006123-200201000-00014

6. Deer, T. R., Serafini, M., Buchser, E., Ferrante, F. M., & Hassenbusch, S. J. (2002). Intrathecal

Bupivacaine for chronic pain: a review of current knowledge. Neuromodulation: Journal of the International Neuromodulation Society, 5(4), 196–207.

7. Kim, P. S., Staats, P. S., Deer, T. R., Iadarola, M. J., & Mannes, A. J. (2019). Intrathecal Drug Delivery for Cancer Pain. In Nervous System Drug Delivery (pp. 501–520). https://doi.org/10.1016/b978-0-12-813997-4.00025-6

8. Yeung, C. Y. (1976). Intrathecal antibiotic therapy for neonatal meningitis. In Archives of Disease in Childhood (Vol. 51, Issue 9, pp. 686–690). https://doi.org/10.1136/adc.51.9.686

Downloads

Published

31.05.2020

Issue

Vol. 24 No. 3 (2020): 24 (3) 2020

Section

Articles

License

Copyright (c) 2020 AUTHOR

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Masilamani, N., & Ganapathy, D. (2020). AWARENESS ABOUT INTRATHECAL DRUG ADMINISTRATION AMONG DENTAL STUDENTS. International Journal of Psychosocial Rehabilitation, 24(3), 5455-5461. https://doi.org/10.61841/b1jg0f33